Noubar Afeyan at the STAT Summit in Boston.Jeff Pinette for STAT

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason on Signal at JasonMast.05.

BOSTON — Over the last year, venture capitalist Noubar Afeyan has watched his signature creation, Moderna Therapeutics, go from perhaps the world’s most celebrated company, hailed for helping ease a once-in-a-century pandemic, to a target of government officials promoting falsehoods about mRNA technology.  

Those attacks, Afeyan warned Thursday, would not end with Moderna or mRNA vaccines. They are a canary in the coal mine for a larger assault on science and expertise, he said. 

Advertisement

“I think the notion that people can play with science, scientific fact, and essentially say opinions could be replaced for facts, or facts should be taken for opinions … isn’t going to stop at mRNA, isn’t going to stop with vaccines, childhood vaccines,” Afeyan said at the STAT Summit in Boston. “It’s going to go to every medicine.”

STAT+ Exclusive Story

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $399/year

$30 for 3 months Get Started

Then $399/year

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe